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Endometrial cancer is the most commonly diagnosed
gynaecological cancer. Although endometrioid endome-
trial cancer (80% of cases) generally carries a good prog-
nosis, some patients with this tumour subtype relapse
within two years. Identifying genetic variants associated
with prognosis could inform clinical decision-making for
management at diagnosis, and inform development of
chemotherapeutic agents targeting aggressive disease.
Genome-wide association studies (GWAS) have been
successful in identifying common genetic variation
involved in cancer susceptibility. Presently there are lim-
ited published studies using GWAS data to identify sin-
gle nucleotide polymorphisms (SNPs) associated with
tumour prognostic indicators, such as grade. We used
case data from an endometrial cancer case-control
GWAS to assess association of SNPs with endometrial
cancer grade. Genome-wide genotyping of 1285 Austra-
lian and British women with endometrioid endometrial
cancer and reporting Caucasian ethnicity was performed
using the Illumina 610K BeadChip. After applying qual-
ity control measures, data on 583,366 SNPs for 1220
cases with grade information were used in the analysis.
PLINK software was used to assess SNP association
with grade (1, 2 or 3), adjusting for study group (Austra-
lian or British). Fifty-seven SNPs were found to be sig-
nificant at <10–4. Two variants with evidence of
association with higher endometrial cancer grade (p-
trend<10–6) have been selected for validation in
independent sample sets. These SNPs are located in or
near genes not previously reported to be involved in
cancer aetiology or prognosis and, if confirmed, would
represent novel gene targets. Neither of these SNPs fall
into the top 1500 SNPs prioritised for validation of asso-
ciation with risk. Results to date suggest that genetic
alleles associated with prognostic features, such as can-
cer grade, may be distinct from those associated with
predisposition. GWAS analysis of tumour prognostic
features is thus likely to improve understanding of bio-
logical pathways influencing outcome for endometrial
cancer patients.
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